Psilocybin helped doctors and nurses who worked through the pandemic
Researchers ran a double-blind, randomized trial in Washington State from February-December 2022. Their study was published in the Journal of the American Medical Association (JAMA) on December 5, 2024.
This randomized clinical trial found that psilocybin therapy resulted in a significant, sustained reduction in symptoms of depression experienced by clinicians after frontline work during the COVID-19 pandemic… Participants and facilitators engaged in what the researchers described as “secular ceremony,” in order “to reinforce the participant’s belief that they could change and to incorporate their own spirituality.”
Original Article (JAMA & Filtermag):
Psilocybin therapy for clinicians with symptoms of depression from frontline care during the COVID-19 pandemic & Psilocybin helped doctors and nurses who worked through the pandemic
Artwork Fair Use: Jü
Recent Comments